Happy Hunting: Tyco Nellcor, Masimo Find Dual-Source Contracts Abet Sales
This article was originally published in The Gray Sheet
Executive Summary
Tyco Nellcor looks to sustain 5% sales growth for its pulse oximetry products in the face of increasing price pressure and competition eroding the firm's more than 80% U.S. market share
You may also be interested in...
Nellcor Seeks Reversal Of $134 Mil. Pulse Oximeter Infringement Jury Award
Tyco unit Nellcor could face treble damages and an injunction against sales following a recent jury finding of willful infringement of four Masimo pulse oximetry patents, according to Masimo
Nellcor Seeks Reversal Of $134 Mil. Pulse Oximeter Infringement Jury Award
Tyco unit Nellcor could face treble damages and an injunction against sales following a recent jury finding of willful infringement of four Masimo pulse oximetry patents, according to Masimo
IPO Flurry In 2004? Aspirants Stress Profitability, Economic Upturn As Key
Increased access to group purchasing contracts - and a subsequent surge in market share - may provide pulse oximeter developer Masimo with the fiscal confidence to pursue an initial public offering during the second half of the year